Tectonic Therapeutic, Inc. short interest in 2023
In 2023, Tectonic Therapeutic, Inc.'s disclosed short interest ran from 0.30% of shares outstanding on 13 Jan 2023 to 1.50% on 29 Dec 2023, a change of +1.20 percentage points. The year's high was 5.43% on 14 Jul 2023 and its low 0.28% on 31 Jan 2023, averaging 3.08% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.10 days on 31 Oct 2023. Full history: Tectonic Therapeutic, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.30% (13 Jan 2023)
- End of year
- 1.50% (29 Dec 2023)
- Change
- +1.20 pp
- High
- 5.43% (14 Jul 2023)
- Low
- 0.28% (31 Jan 2023)
- Average
- 3.08%
- Highest days to cover
- 13.10 (31 Oct 2023)
- SEC filings marked
- 6
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.30% | 1.00 | |
| 31 Jan 2023 | 0.28% | 1.00 | |
| 31 Mar 2023 | 2.49% | 2.31 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 2.33% | 3.84 | |
| 28 Apr 2023 | 2.21% | 5.21 | |
| 15 May 2023 | 2.23% | 1.78 | 10-Q filed, results (8-K) |
| 31 May 2023 | 3.23% | 1.00 | |
| 15 Jun 2023 | 3.39% | 1.11 | |
| 30 Jun 2023 | 3.03% | 1.80 | |
| 14 Jul 2023 | 5.43% | 1.00 | |
| 31 Jul 2023 | 4.64% | 1.73 | |
| 15 Aug 2023 | 4.88% | 4.52 | 10-Q filed |
| 31 Aug 2023 | 3.98% | 4.70 | |
| 15 Sep 2023 | 3.89% | 3.76 | |
| 29 Sep 2023 | 4.72% | 9.43 | |
| 13 Oct 2023 | 5.06% | 7.56 | |
| 31 Oct 2023 | 5.18% | 13.10 | |
| 15 Nov 2023 | 2.16% | 1.50 | 10-Q filed |
| 30 Nov 2023 | 2.06% | 3.44 | |
| 15 Dec 2023 | 1.60% | 4.60 | |
| 29 Dec 2023 | 1.50% | 6.59 |
See also: Tectonic Therapeutic, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.